Hepatic encephalopathy (HE) can cause major morbidity despite standard of care (SOC;
rifaximin/lactulose). Fecal microbial transplant (FMT) enemas postantibiotics are safe, but …

Early data suggest fecal microbiota transplant (FMT) may treat hepatic encephalopathy (HE).
Optimal FMT donor and recipient characteristics are unknown. We assessed the safety and …

Simple Summary Treatment of advanced liver disease and its complications continue to be a
challenge due to the complexity of this illness. In recent years, the gut microbiome has been …

Recurrent hepatic encephalopathy (HE) is a leading cause of readmission despite standard
of care (SOC) associated with microbial dysbiosis. Fecal microbiota transplantation (FMT) …

Hepatic encephalopathy (HE) is a reversible neurocognitive dysfunction that ranges in
severity from subclinical alterations to coma. Patients with chronic liver disease are …

BACKGROUND Hepatic encephalopathy (HE) is associated with poor outcomes. A prior
randomized, pilot trial demonstrated safety after oral capsular fecal microbial transplant …

Discussion To our knowledge, this is the first report of treating HE with FMT. In this case, the
dramatic clinical improvements, both subjectively and objectively, following serial FMT are …

Methods: For rational donor selection, the microbiome profile of HE patients and healthy
controls were assessed. HE patients demonstrated a relative reduction of Lachnospiraceae …

Antibiotic resistance leads to poor outcomes in cirrhosis. Fecal microbiota transplant (FMT)
is associated with reduction in antibiotic resistance gene (ARG) burden in patients without …

Cirrhosis and hepatic encephalopathy (HE) is associated with an altered gut–liver–brain
axis. Fecal microbial transplant (FMT) after antibiotics improves outcomes in HE, but the …